Table 3.
Physician motivations for infliximab dose rounding and ranked choice scores.
| Motivation for rounding | Number that chose as one of their reasons | Ranked choice scorea |
|---|---|---|
| Reduce drug left in the vial | 18 (58.06%) | 6.29 |
| To achieve therapeutic drug levels | 11 (35.48%) | 6.00 |
| It is easier to record and remember rounded numbers | 9 (29.03%) | 6.25 |
| Considering disease activity (moderate vs severe) | 8 (25.81%) | 5.57 |
| Reduce cost of treatment | 4 (12.90%) | 6.00 |
| Decrease risk of infusion reactions | 1 (3.23%) | 3.00 |
| Otherb | 7 (22.58%) | 7.00 |
A higher value in the ranked choice score demonstrates a more important motivating factor in a physician’s decision to round their infliximab prescription.
Three physicians reported that they deferred to pharmacy/infusion center policies and preferences, two physicians were concerned with ease and accuracy of administration, 1 physician focused on alleviating medication waste, and 1 physician named financial waste as a motivating factor.